Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Accumulated Expenses (2016 - 2026)

Biomerica's Accumulated Expenses history spans 16 years, with the latest figure at $608000.0 for Q1 2026.

  • Quarterly results put Accumulated Expenses at $608000.0 for Q1 2026, down 0.65% from a year ago — trailing twelve months through Feb 2026 was $608000.0 (down 0.65% YoY), and the annual figure for FY2025 was $655000.0, up 13.32%.
  • Accumulated Expenses for Q1 2026 was $608000.0 at Biomerica, up from $545000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $702000.0 in Q1 2024 to a low of $236000.0 in Q2 2022.
  • The 5-year median for Accumulated Expenses is $601000.0 (2024), against an average of $588286.4.
  • The sharpest move saw Accumulated Expenses surged 132.2% in 2023, then dropped 12.82% in 2025.
  • Year by year, Accumulated Expenses stood at $697179.0 in 2022, then dropped by 4.19% to $668000.0 in 2023, then decreased by 10.03% to $601000.0 in 2024, then decreased by 9.32% to $545000.0 in 2025, then increased by 11.56% to $608000.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $608000.0, $545000.0, and $591000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.